JP2022538375A5 - - Google Patents
Info
- Publication number
- JP2022538375A5 JP2022538375A5 JP2021560586A JP2021560586A JP2022538375A5 JP 2022538375 A5 JP2022538375 A5 JP 2022538375A5 JP 2021560586 A JP2021560586 A JP 2021560586A JP 2021560586 A JP2021560586 A JP 2021560586A JP 2022538375 A5 JP2022538375 A5 JP 2022538375A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- seq
- acid sequence
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910286677 | 2019-04-10 | ||
| CN201910286677.9 | 2019-04-10 | ||
| PCT/CN2020/083954 WO2020207432A1 (en) | 2019-04-10 | 2020-04-09 | Antibody Binding to PD-1 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022538375A JP2022538375A (ja) | 2022-09-02 |
| JP2022538375A5 true JP2022538375A5 (enExample) | 2024-10-09 |
| JP7641910B2 JP7641910B2 (ja) | 2025-03-07 |
Family
ID=72750942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560586A Active JP7641910B2 (ja) | 2019-04-10 | 2020-04-09 | Ｐｄ－１と結合する抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12466887B2 (enExample) |
| EP (1) | EP3931223A4 (enExample) |
| JP (1) | JP7641910B2 (enExample) |
| CN (2) | CN111808190B (enExample) |
| AR (1) | AR118619A1 (enExample) |
| WO (1) | WO2020207432A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115776898A (zh) * | 2020-07-07 | 2023-03-10 | 百奥泰生物制药股份有限公司 | 双特异性抗体及其应用 |
| CN121668303A (zh) * | 2020-10-11 | 2026-03-17 | 百奥泰生物制药股份有限公司 | 抗pd-1抗体在联合用药中的应用 |
| WO2025140324A1 (zh) * | 2023-12-26 | 2025-07-03 | 百奥泰生物制药股份有限公司 | 抗pd-1抗体联合化疗剂在治疗肿瘤中的用途 |
| WO2025190251A1 (zh) * | 2024-03-12 | 2025-09-18 | 百奥泰生物制药股份有限公司 | 抗trop2抗体药物偶联物和pd-1拮抗剂联合治疗实体瘤的用途 |
| CN120919340A (zh) * | 2024-05-09 | 2025-11-11 | 百奥泰生物制药股份有限公司 | 抗FRα抗体药物偶联物和PD-1拮抗剂在治疗肿瘤中的应用 |
| CN121015902A (zh) * | 2024-05-27 | 2025-11-28 | 百奥泰生物制药股份有限公司 | 抗trop2抗体药物偶联物和抗pd-l1/cd47双特异抗体联合治疗肿瘤的用途 |
| CN121754666A (zh) * | 2024-09-30 | 2026-03-31 | 百奥泰生物制药股份有限公司 | 一种抗pd-1抗体制剂及其制备方法和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6699658B1 (en) * | 1996-05-31 | 2004-03-02 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| KR101586617B1 (ko) * | 2007-06-18 | 2016-01-20 | 머크 샤프 앤 도메 비.브이. | 사람 프로그램된 사멸 수용체 ｐｄ-1에 대한 항체 |
| AU2016333517B2 (en) | 2015-10-02 | 2023-09-07 | Les Laboratoires Servier | Anti-PD-1 antibodies and compositions |
| WO2018181064A1 (ja) | 2017-03-27 | 2018-10-04 | 国立大学法人北海道大学 | Ｐｄ－ｌ１検出用抗ｐｄ－ｌ１抗体 |
| WO2018217227A1 (en) * | 2017-05-24 | 2018-11-29 | Immunomedics, Inc. | Novel anti-pd-1 checkpoint inhibitor antibodies that block binding of pd-l1 to pd-1 |
| CN108997499B (zh) | 2018-09-12 | 2020-07-31 | 首都医科大学附属北京胸科医院 | 一种抗人pd-l1抗体及其应用 |
-
2020
- 2020-04-08 AR ARP200100982A patent/AR118619A1/es unknown
- 2020-04-09 CN CN202010275368.4A patent/CN111808190B/zh active Active
- 2020-04-09 WO PCT/CN2020/083954 patent/WO2020207432A1/en not_active Ceased
- 2020-04-09 EP EP20788554.2A patent/EP3931223A4/en active Pending
- 2020-04-09 US US17/602,715 patent/US12466887B2/en active Active
- 2020-04-09 JP JP2021560586A patent/JP7641910B2/ja active Active
- 2020-04-09 CN CN202311534081.9A patent/CN117603355A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Volante et al. | Molecular pathology of poorly differentiated and anaplastic thyroid cancer: what do pathologists need to know? | |
| Liu et al. | Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation | |
| WO2000053755A3 (en) | Compositions and methods for the treatment of tumor | |
| JP2024026191A5 (enExample) | ||
| EP3674312A2 (en) | Novel polypeptide and method for producing imp using same | |
| JP2021511811A5 (enExample) | ||
| Katoh | Expression and regulation of WNT1 in human cancer: up-regulation of WNT1 by β-estradiol in MCF-7 cells | |
| PT1623990E (pt) | Composições e métodos para o tratamento de tumores | |
| WO2000075317A3 (en) | Compositions and methods for the treatment of tumor | |
| IL193366A0 (en) | Fibroblast growth factor -19 | |
| CN105384818A (zh) | 抗人Delta like 4单克隆抗体及其应用 | |
| EP3839045B1 (en) | Amino acid dehydrogenase mutant and application thereof | |
| EP1642968A3 (en) | Composition and methods for the diagnosis of tumours | |
| CA2579391A1 (en) | Anti-a33 antibody | |
| CA2532460A1 (en) | Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof | |
| JP2021522190A5 (enExample) | ||
| WO2000037640A3 (en) | Compositions and methods for the treatment of tumor | |
| CA2343980A1 (en) | Mammaglobin, a secreted mammary-specific breast cancer protein | |
| CN120193031A (zh) | 一种苯甲醛裂合酶突变体催化的氨基醇类化合物的合成方法和应用 | |
| CN102875684A (zh) | Fgfr单链抗体融合蛋白及其在制备靶向肿瘤细胞药物中的应用 | |
| CN111978389A (zh) | 一种高效抑制端粒酶活性片段、其融合蛋白及其制备方法和应用 | |
| CN103923955A (zh) | 一种生产l-丙氨酸的方法 | |
| Hahne et al. | Biomarkers for monitoring response to therapies and detection of acquired resistance in advanced gastrointestinal cancers | |
| US20040142328A1 (en) | Method and cloning vector for preparing multiple-gene diagnostic probes for the assessment of multiple markers for breast cancer prognosis | |
| Moradi et al. | Helicobacter pylori cagA-positive strains: gastric cancer susceptibility |